These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2576226

  • 1. Beta-adrenoceptor blockade in rats enhances the ambulation induced by 5-HT1A receptor agonists.
    Kalkman HO.
    Eur J Pharmacol; 1989 Dec 07; 173(2-3):121-5. PubMed ID: 2576226
    [Abstract] [Full Text] [Related]

  • 2. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO, Soar J.
    Eur J Pharmacol; 1990 Dec 04; 191(3):383-90. PubMed ID: 2150821
    [Abstract] [Full Text] [Related]

  • 3. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
    Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG.
    Eur J Pharmacol; 1990 Feb 13; 176(3):331-40. PubMed ID: 1970304
    [Abstract] [Full Text] [Related]

  • 7. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 13; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 5-HT1A receptor antagonists and lordosis behavior.
    Uphouse L, Andrade M, Caldarola-Pastuszka M, Jackson A.
    Neuropharmacology; 1996 Apr 13; 35(4):489-95. PubMed ID: 8793912
    [Abstract] [Full Text] [Related]

  • 12. Antagonism by pindolol, but not betaxolol, of 8-OH-DPAT-induced facilitation of male rat sexual behavior.
    Ahlenius S, Larsson K.
    J Neural Transm; 1989 Apr 13; 77(2-3):163-70. PubMed ID: 2569497
    [Abstract] [Full Text] [Related]

  • 13. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K, Millan MJ, Colpaert FC.
    Eur J Pharmacol; 1990 Nov 27; 191(2):185-95. PubMed ID: 2150818
    [Abstract] [Full Text] [Related]

  • 14. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
    Gilbert F, Brazell C, Tricklebank MD, Stahl SM.
    Eur J Pharmacol; 1988 Mar 15; 147(3):431-9. PubMed ID: 2897920
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R, Brocco M, Lefèbvre de Ladonchamps B, Monneyron S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 15; 275(2):822-31. PubMed ID: 7473172
    [Abstract] [Full Text] [Related]

  • 17. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ, Rivet JM, Canton H, Le Marouille-Girardon S, Gobert A.
    J Pharmacol Exp Ther; 1993 Mar 15; 264(3):1364-76. PubMed ID: 8450471
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH, Wouters W, Saxena PR.
    Eur J Pharmacol; 1990 May 16; 180(2-3):339-49. PubMed ID: 2142096
    [Abstract] [Full Text] [Related]

  • 20. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
    Sanders KH, Beller KD, Kolassa N.
    J Cardiovasc Pharmacol; 1990 May 16; 15 Suppl 7():S86-93. PubMed ID: 1702492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.